Emergent BioSolutions Inc. — Director's Dealing 2019

May 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2019-05-08

Reporting Person: LINDAHL RICHARD S (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-08	Common Stock	F	759	$47.49	Disposed	20937	Direct

Footnotes

F1: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.